DOMAIN
|
Competency Standard
|
1. |
Conduct testing and diagnosis of HIV |
|
1.1 |
Understand and perform various HIV testing options. |
1.2 |
Understand and perform CD4 Testing. |
1.3 |
Conduct Pharmacist-Initiated Counselling and Testing (PhICT). |
1.4 |
Provide Risk Reduction Counselling. |
1.5 |
Use immunological and virological parameters in understanding the severity of HIV infection. |
|
2. |
Initiate pre-exposure prophylaxis (PrEP), post-exposure prophylaxis (PEP) and 1st line antiretroviral therapy (ART) plus the initiation of TB-preventative therapy (TPT) where appropriate and apply protocol adherence measures |
|
2.1 |
Demonstrate knowledge of ART Principles. |
2.2 |
Prepare patients for ART adherence. |
2.3 |
Identify, classify, and analyse the various types of ARTs and their side effects and toxicities. |
2.5 |
Analyse ART medicine choices in PrEP and PEP, and considerations around pharmacology and drug interactions, including TPT. |
2.6 |
Identify and manage PrEP, PEP and ART contra-indications. |
2.7 |
Conduct PEP in the PIMART environment. |
|
3. |
Implement processes for the prevention of HIV transmission and infection via PrEP, safer conception and contraception, and prevention of mother to child transmission (PMTCT) |
|
3.1 |
Implement PrEP in the PIMART environment. |
3.2 |
Conduct pregnancy screening and recommend contraception in the PIMART context. |
3.3 |
Implement pre-conception management for HIV positive couples. |
3.4 |
Demonstrate knowledge of PMTCT and the rationale for PMTCT programmes. |
|
4. |
Implement processes to identify and manage co-morbidities and opportunistic infections related to HIV |
|
4.1 |
Manage HIV co-morbidities. |
4.2 |
Identify and manage common opportunistic infections. |
4.3 |
Manage TB and HIV co-infection. |
4.4 |
Promote TB prevention. |
|
5. |
Implement processes to prevent and manage drug interactions and drug resistance |
|
5.1 |
Understand the importance of drug interactions, e.g. drug/drug and drug/disease. |
5.2 |
Demonstrate in-depth knowledge of various ART drug interactions. |
5.3 |
Prevent adverse drug interactions and reactions. |
5.4 |
Define the types and consequences of drug resistance. |
|
6. |
Handle ART data responsibly and use disease management systems appropriately |
|
6.1 |
Generate reports to assist with clinical governance, programme management and quality improvement. |
6.2 |
Use a Patient Management System. |
6.3 |
Implement the process of care for PIMART. |
6.4 |
Apply minimum package of interventions to support linkage to care. |
|